Advertisement
News
Advertisement

AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association

Tue, 08/09/2011 - 11:38am
Bio-Medicine.Org

CENTENNIAL, Colo., Aug. 9, 2011 /PRNewswire/ -- AlloSource, a leading developer, processor and distributor of bone and soft-tissue allografts for use in surgical procedures around the world, today announced two new key affiliations with the Alliance for Regenerative Medicine (ARM) and the Medical Device Manufacturers Association (MDMA).  AlloSource pursued membership with both organizations in order to support medical device and regenerative medicine grassroots efforts with policy makers.

ARM is a nonprofit whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies to facilitate advances in the field. MDMA is a national trade association providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies.  Both organizations have already made progress in growing the knowledge base of Capitol Hill influencers on the current industry issues that affect their member organizations.

"AlloSource honors the gift of life from donors and their families by safely and respectfully processing donated tissue, and because of this we are dedicated to expanding the medical possibilities of tissue transplantation," Thomas Cycyota, AlloSource President and CEO.  "We look forward to working with the Alliance for Regenerative Medicine and the Medical Device Manufacturers Association to educate regulators on the ways regenerative medicine and medical devices using donated tissue do and will continue to greatly improve the quality of life for millions of patients in need."

AlloSource recently expanded its product offerings with the addition of AlloStem® Stem Cell Bone Growth Substitute, which pioneers the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications, helping to stimulate natural bone formation. Through the osteobiologics products they produce, the company has facilitated approximat

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading